Actively Recruiting
The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer
Led by Kafkas University · Updated on 2024-08-14
105
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Breast cancer is defined as the most common type of cancer that causes death among women (Siegel et al. 2019). It constitutes 24% of cancers and 15% of cancer-related deaths in women (T.R. Ministry of Health 2020). According to statistics made towards the end of 2020, there are 7.8 million women in the world who were diagnosed with breast cancer in the last 5 years and are alive. It is estimated that one in every 8 women will develop breast cancer in developed countries (WHO 2021). The Ministry of Health reported the frequency of breast cancer in our country as 45.6/100,000 in women in 2018. The incidence of breast cancer is reported to be higher, especially in the 45-54 age range (TC Ministry of Health 2020). Chemotherapy is one of the most frequently preferred treatment methods in the treatment of breast cancer and can cause serious side effects such as pain, nausea and vomiting, loss of appetite, shortness of breath, mouth sores, fatigue, insomnia, anxiety and depression, and may lead to a deterioration in the quality of life of patients (Waks and Winer 2019, Samami et al. 2021, Sajadian et al. 2017, McFarland et al. 2018, Hamer et al. 2017). In the international and national literature, no study has been found comparing the effects of laughter and mindfulness therapy on the anxiety, depression, quality of life and spiritual well-being experienced by breast cancer patients. In this study, it is planned to investigate the effects of laughter and mindfulness therapy applications on the anxiety, depression, quality of life and spiritual well-being levels of women with breast cancer receiving chemotherapy.
CONDITIONS
Official Title
The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 years or older
- Women with stage 1 or stage 2 breast cancer
- Women receiving chemotherapy at least once a month and continuing treatment during the study
- Women with no communication problems
- Women who have and can use a smartphone with internet access for online sessions
- Women within the first year of chemotherapy treatment
- Women with a Hospital Anxiety and Depression Scale score of 8 or higher
- Women who volunteer to participate in the study
- Women with primary or secondary education
You will not qualify if you...
- Women who do not meet inclusion criteria
- Women who refuse to participate or attend less than 80% of sessions
- Women who currently use mindfulness therapy, laughter therapy, or complementary medicine outside the study
- Women with a diagnosed psychological disease
- Women with cancer metastasis or recurrence
- Women whose chemotherapy treatment ends before study completion
- Women with stage 3 or stage 4 breast cancer
- Women who have been receiving chemotherapy for more than one year
- Women with a Hospital Anxiety and Depression Scale score of 8 or below
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hatay Iskenderun State Hospital
İskenderun, Hatay, Turkey (Türkiye)
Actively Recruiting
Research Team
Z
Zehra Coktay, phd stu
CONTACT
R
Rukiye Turk Delibalta, assoc prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here